552 reports of this reaction
2.1% of all DOCOSANOL reports
#8 most reported adverse reaction
LIP SWELLING is the #8 most commonly reported adverse reaction for DOCOSANOL, manufactured by Haleon US Holdings LLC. There are 552 FDA adverse event reports linking DOCOSANOL to LIP SWELLING. This represents approximately 2.1% of all 26,055 adverse event reports for this drug.
Patients taking DOCOSANOL who experience lip swelling should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
LIP SWELLING is a less commonly reported adverse event for DOCOSANOL, but still significant enough to appear in the safety profile.
In addition to lip swelling, the following adverse reactions have been reported for DOCOSANOL:
The following drugs have also been linked to lip swelling in FDA adverse event reports:
LIP SWELLING has been reported as an adverse event in 552 FDA reports for DOCOSANOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
LIP SWELLING accounts for approximately 2.1% of all adverse event reports for DOCOSANOL, making it a notable side effect.
If you experience lip swelling while taking DOCOSANOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.